Semaglutide 30mg

Product overview

Semaglutide is a selective GLP-1 receptor agonist peptide — a distinct incretin from dual-agonist tirzepatide and triple-agonist GLP-3 RT (retatrutide). VaultLabs supplies Semaglutide 30mg lyophilized research material for UAE in vitro laboratory programmes with lot-tracked documentation when published. Research use only — not for human consumption, medical use, or personal application.

Lyophilized incretin peptide · HPLC verification on published COA · VaultLabs code VL-SEMA-30 · Appearance: White to off-white lyophilized powder

Technical specifications

Full product name

Semaglutide 30mg

Product category

Research Peptides

Product code

VL-SEMA-30

Strength / amount

30 mg

Physical form

Lyophilized

Purity

99.9%

Testing method

HPLC

Laboratory

VaultLabs Laboratory

Test date

2026-07-15

Current lot number

VL-SEMA-20260801

Manufacturing / packaging date

2026-07-01

Country of origin

United Arab Emirates (dispatch)

Chemical identifiers

Chemical name

Semaglutide

CAS number

910463-68-2

Molecular formula

C187H291N45O59

Molecular weight

4113.58 g/mol

Synonyms

GLP-1 receptor agonist peptide, NN9535

Product code

VL-SEMA-30

Grade

Research grade — for in vitro laboratory research use only

Material class

Lyophilized incretin peptide

Current batch documentation

Storage and handling

2–8 °C · protect from light

Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Shipping information

Shipping / packaging

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

Availability

In stock

Dispatch estimate

Dispatched within 24 hours, 7 days a week

VAT

5% VAT (AED) where applicable